138 related articles for article (PubMed ID: 36841785)
1. Kratom Retail Availability in Fort Worth, Texas.
LoParco CR; Yockey RA; Sekhon VK; Olsson S; Galindo R; Balasundaram R; Agwuncha T; Rossheim ME
J Psychoactive Drugs; 2024; 56(1):8-13. PubMed ID: 36841785
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Delta-8 THC Retail Availability in Fort Worth, Texas, 2021-2022.
LoParco CR; Kong AY; Yockey RA; Sekhon V; Olsson S; Rossheim ME
Subst Use Misuse; 2024; 59(6):840-846. PubMed ID: 38247162
[No Abstract] [Full Text] [Related]
3. Delta-8 THC Retail Availability, Price, and Minimum Purchase Age.
Rossheim ME; LoParco CR; Walker A; Livingston MD; Trangenstein PJ; Olsson S; McDonald KK; Yockey RA; Luningham JM; Kong AY; Henry D; Walters ST; Thombs DL; Jernigan DH
Cannabis Cannabinoid Res; 2024 Feb; 9(1):363-370. PubMed ID: 36342930
[No Abstract] [Full Text] [Related]
4. How Are Retailers Describing Delta-8 THC?A Mixed-Methods Study in Fort Worth, Texas.
LoParco CR; Olsson SE; Greene KM; Livingston MD; Henry D; Trangenstein PJ; Walker A; Rossheim ME
J Stud Alcohol Drugs; 2023 Mar; 84(2):298-302. PubMed ID: 36971730
[TBL] [Abstract][Full Text] [Related]
5. Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023.
Rossheim ME; LoParco CR; Berg CJ; Tillett KK; Trangenstein PJ; Henry D; Yockey RA; Livingston MD; Jernigan DH; Sussman SY
Drug Alcohol Depend; 2024 Mar; 256():111119. PubMed ID: 38350186
[TBL] [Abstract][Full Text] [Related]
6. Kratom availability in California vape shops.
Bowdring MA; Leas EC; Vishwakarma M; Schleicher NC; Prochaska JJ; Henriksen L
Prev Med Rep; 2023 Oct; 35():102380. PubMed ID: 37680858
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
[TBL] [Abstract][Full Text] [Related]
8. Examining the Psychoactive Differences between Kratom Strains.
Huisman G; Menke M; Grundmann O; Schreiber R; Mason N
Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510657
[TBL] [Abstract][Full Text] [Related]
9. Exploring the self-reported motivations of kratom (
Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
[No Abstract] [Full Text] [Related]
10. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
[TBL] [Abstract][Full Text] [Related]
11. For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic.
Rogers JM; Smith KE; Schriefer D; Epstein DH
Subst Abuse; 2022; 16():11782218221123977. PubMed ID: 36199697
[TBL] [Abstract][Full Text] [Related]
12. Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH).
Falise AM; Hoeflich CC; Nutley SK; Lopez-Quintero C; Striley CW
Am J Addict; 2023 Jan; 32(1):76-80. PubMed ID: 36222599
[TBL] [Abstract][Full Text] [Related]
13. A Preliminary Inventory of Kratom
Prevete E; Catalani V; Singh D; Kuypers KPC; Theunissen EL; Townshend HD; Banayoti H; Ramaekers JG; Pasquini M; Corazza O
J Psychoactive Drugs; 2023 Sep; ():1-11. PubMed ID: 37702482
[TBL] [Abstract][Full Text] [Related]
14. Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.
Cinosi E; Martinotti G; Simonato P; Singh D; Demetrovics Z; Roman-Urrestarazu A; Bersani FS; Vicknasingam B; Piazzon G; Li JH; Yu WJ; Kapitány-Fövény M; Farkas J; Di Giannantonio M; Corazza O
Biomed Res Int; 2015; 2015():968786. PubMed ID: 26640804
[TBL] [Abstract][Full Text] [Related]
15. A Cross-sectional Analysis of Socio-spatial Patterning of Tobacco Retail in Shanghai, China.
Zheng C; Feng Z; Pearce J
Nicotine Tob Res; 2022 Nov; 24(12):2018-2025. PubMed ID: 35777980
[TBL] [Abstract][Full Text] [Related]
16. Commercial Delta-8 THC Products: an Analysis of Content and Labeling.
Kaczor EE; Greene K; Babu KM; Berthold EC; Sharma A; Carreiro SP
J Med Toxicol; 2024 Jan; 20(1):31-38. PubMed ID: 37917314
[TBL] [Abstract][Full Text] [Related]
17. Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada.
Ng JY; Ans M; Marwaha A
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):23. PubMed ID: 33741009
[TBL] [Abstract][Full Text] [Related]
18. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
19. Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Grundmann O; Veltri CA; Morcos S; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
Exp Clin Psychopharmacol; 2023 Oct; 31(5):963-977. PubMed ID: 36634016
[TBL] [Abstract][Full Text] [Related]
20. Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects.
Grundmann O; Hill K; Al Barzanji E; Hazrat NG; Kaur G; Negeve RE; Shade S; Weber S; Veltri CA
J Ethnopharmacol; 2023 Dec; 317():116779. PubMed ID: 37364801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
